This inventor holds 2 USPTO granted patents. Top assignees: Antex Biologics, Inc., Emergent Product Development Gaithersburg Inc.. Active years: 2003-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 18 
1 out of 23 Years Active: 2003-2007
Title: The Innovative Journey of Ulrich F Tillmann
Introduction
Ulrich F Tillmann is a notable inventor based in Olney, MD, USA, recognized for his significant contributions to the field of biotechnology. With a portfolio boasting two patents, Tillmann has focused his research on developing innovative solutions for medical applications, particularly in immunology.
Latest Patents
Among his latest inventions is a groundbreaking patent that discloses the outer membrane protein polypeptide known as OMP21, along with its nucleotide sequences and the antibodies that specifically bind to it. This invention presents pharmaceutical compositions that include prophylactic or therapeutic applications, which may consist of immunogenic compositions such as vaccines incorporating OMP21, antibodies, or nucleotides encoding the polypeptide. Furthermore, this patent outlines methods to induce an immune response against OMP21 in humans, alongside methodologies for diagnosing and treating infections caused by Moraxella catarrhalis, thereby enhancing therapeutic strategies in infectious disease management.
Career Highlights
Throughout his career, Tillmann has been associated with several esteemed companies in the biotechnology sector, including Antex Biologics, Inc. and Emergent Product Development in Gaithersburg, Maryland. His work at these companies has played a vital role in advancing immunological research and product development.
Collaborations
Ulrich F Tillmann has worked alongside notable professionals in his field, including his coworker Kenneth D Tucker. This collaboration has contributed to enriching the research landscape, fostering advancements in their shared areas of expertise.
Conclusion
Ulrich F Tillmann exemplifies the spirit of innovation and dedication within the biotechnology sector. His research and patents reflect a commitment to improving healthcare outcomes through scientific advancements. As he continues to explore new frontiers in biomedicine, Tillmann's work remains essential to the evolution of therapeutic solutions aimed at combating infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile